Browse by Author "Massuti, B."

Now showing items 1-5 of 5

Agreement Between Different Methodologies for Non-Invasive p.T790M and EGFR Sensitizing Mutation Testing

2019- Romero, A.; Jantus, E.; Molina-Vila, M. A.; Insa, A.; Cruz, P.; [et al.]
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

2019- Conde, E.; Hernandez, S.; Martinez, R.; Angulo, B.; De Castro, J.; [et al.]
Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

2020- Isla, D.; Massuti, B.; Lazaro Quintela, Martín; de Alda, L. R.; Gordo, R.; [et al.]
Reccurrence Pattern After Adjuvant Customized Chemotherapy Based on BRCA Expression Level (SCAT Trial)

2019- Massuti, B.; Sanchez, J. M.; Cobo, M.; Moran, T.; Larriba, J. L. G.; [et al.]
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

2022- Casarrubios, M.; Provencio, M.; Nadal, E.; Insa, A.; García Campelo, María del Rosario; [et al.]